Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

The document discusses how to identify and manage common skin conditions in children.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Wen by Chaz Dean Sweet Almond Mint Cleansing Conditioner is better tolerated than salicylic acid and baby shampoos.

Some psychiatric drugs can cause skin problems, but serious reactions are rare.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Skin treatment can lower life quality for patients with skin conditions.

Skin issues can signal substance use, helping early detection and treatment.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Nilotinib can cause skin issues like red bumps and hair loss.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Biologics for severe asthma have known side effects, but some new risks need more study.